A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors
Clinical trial NCT07274813 · RECRUITING
Trial details
- NCT number
- NCT07274813
- Sponsor
- Shanghai Henlius Biotech
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-29
- Primary completion
- 2027-03-30
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.